Literature DB >> 15862111

Particulate delivery systems for vaccines.

Vincent W Bramwell1, Yvonne Perrie.   

Abstract

This review focuses on the use of particulate delivery systems for the purposes of immunization. This includes poly(lactide-co-glycolide) (PLGA), ISCOMs, liposomes, niosomes, virosomes, chitosan, and other biodegradable polymers. These systems are evaluated in terms of their use as carriers for protein subunit and DNA vaccines. There is an extensive focus on recent literature, the understanding of biological interactions, and relation of this to our present understanding of immunological mechanisms of action. In addition, there is consideration of formulation techniques including emulsification, solvent diffusion, DNA complexation, and entrapment. The diversity of formulation strategies presented is a testament to the exponential growth and interest in the area of vaccine delivery systems. A case study for the application of particulate vaccine carriers is assessed in terms of vaccine development and recent insights into the possible design and application of vaccines against two of the most important pathogens that threaten mankind and for which there is a significant need: Mycobacterium tuberculosis and human immunodeficiency virus. This review addresses the rationale for the use of particulate delivery systems in vaccine design in the context of the diversity of carriers for DNA- and protein-based vaccines and their potential for application in terms of the critical need for effective vaccines.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15862111     DOI: 10.1615/critrevtherdrugcarriersyst.v22.i2.20

Source DB:  PubMed          Journal:  Crit Rev Ther Drug Carrier Syst        ISSN: 0743-4863            Impact factor:   4.889


  10 in total

1.  Blood stage merozoite surface protein conjugated to nanoparticles induce potent parasite inhibitory antibodies.

Authors:  Kae Pusic; Hengyi Xu; Andrew Stridiron; Zoraida Aguilar; Andrew Wang; George Hui
Journal:  Vaccine       Date:  2011-09-28       Impact factor: 3.641

2.  Conjugation to nickel-chelating nanolipoprotein particles increases the potency and efficacy of subunit vaccines to prevent West Nile encephalitis.

Authors:  Nicholas O Fischer; Ernesto Infante; Tomohiro Ishikawa; Craig D Blanchette; Nigel Bourne; Paul D Hoeprich; Peter W Mason
Journal:  Bioconjug Chem       Date:  2010-06-16       Impact factor: 4.774

3.  Lambda phage nanoparticles displaying HER2-derived E75 peptide induce effective E75-CD8+ T response.

Authors:  Atefeh Arab; Jessica Nicastro; Roderick Slavcev; Atefeh Razazan; Nastaran Barati; Amin Reza Nikpoor; Amir Abbas Momtazi Brojeni; Fatemeh Mosaffa; Ali Badiee; Mahmoud Reza Jaafari; Javad Behravan
Journal:  Immunol Res       Date:  2018-02       Impact factor: 2.829

4.  T-cell activation by antigen-loaded pH-sensitive hydrogel particles in vivo: the effect of particle size.

Authors:  Joel A Cohen; Tristan T Beaudette; William W Tseng; Eric M Bachelder; Ines Mende; Edgar G Engleman; Jean M J Fréchet
Journal:  Bioconjug Chem       Date:  2009-01       Impact factor: 4.774

5.  A microsphere-based vaccine prevents and reverses new-onset autoimmune diabetes.

Authors:  Brett Phillips; Karen Nylander; Jo Harnaha; Jennifer Machen; Robert Lakomy; Alexis Styche; Kimberly Gillis; Larry Brown; Debra Lafreniere; Michael Gallo; Janet Knox; Kenneth Hogeland; Massimo Trucco; Nick Giannoukakis
Journal:  Diabetes       Date:  2008-03-03       Impact factor: 9.461

6.  Induction of protective anti-CTL epitope responses against HER-2-positive breast cancer based on multivalent T7 phage nanoparticles.

Authors:  Somayeh Pouyanfard; Taravat Bamdad; Hamidreza Hashemi; Mojgan Bandehpour; Bahram Kazemi
Journal:  PLoS One       Date:  2012-11-15       Impact factor: 3.240

7.  The mechanisms of action of vaccines containing aluminum adjuvants: an in vitro vs in vivo paradigm.

Authors:  Tirth Raj Ghimire
Journal:  Springerplus       Date:  2015-04-16

Review 8.  The rational design of vaccines.

Authors:  Vincent W Bramwell; Yvonne Perrie
Journal:  Drug Discov Today       Date:  2005-11-15       Impact factor: 7.851

Review 9.  Bone Regeneration from PLGA Micro-Nanoparticles.

Authors:  Inmaculada Ortega-Oller; Miguel Padial-Molina; Pablo Galindo-Moreno; Francisco O'Valle; Ana Belén Jódar-Reyes; Jose Manuel Peula-García
Journal:  Biomed Res Int       Date:  2015-10-05       Impact factor: 3.411

10.  [Immunity and antiviral vaccinations. Example: the respiratory mucosa].

Authors:  F Denis; S Hantz; S Alain
Journal:  Antibiotiques (Paris)       Date:  2008-01-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.